Accueil › Annuaire des chercheurs › Jose Luis Marco
Jose Luis Marco
Affiliation : Consejo Superior de Investigaciones Científicas · Instituto de Salud Carlos III · Centre for Biomedical Network Research on Rare Diseases · Instituto de Química Orgánica General
- 34Publications (affiliation espagnole)
- 486Publications au total
- 12488Citations
- 58Indice h
Profil de recherche
Jose Luis Marco compte 34 publications référencées (2010–2025). Ses travaux paraissent principalement dans « ChemistrySelect », « Molecules » et « Synthetic Communications ». Son article le plus cité, « Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amin » (2012), a été cité 69 fois. 5 de ces publications datent des trois dernières années d’activité. Ses travaux sont cosignés avec au moins 12 chercheurs, notamment dans des établissements de Tunisie.
C’est vous ? Faites connaître vos travaux
Créez gratuitement votre profil DzCademia et ajoutez vos articles : ils apparaîtront plus facilement sur Google et dans les assistants d’IA comme ChatGPT. Plus de personnes pourront vous lire et vous citer.
Créer mon profil gratuit Ajouter mes publicationsDomaines de recherche
- Cholinesterase and Neurodegenerative Diseases
- Organic Chemistry Synthesis Methods
- Synthesis and biological activity
- Alzheimer's disease research and treatments
- Carbohydrate Chemistry and Synthesis
Publications (34)
- Multicomponent Synthesis of Multi-Target Quinazolines Modulating Cholinesterase, Oxidative Stress, and Amyloid Aggregation Activities for the Therapy of Alzheimer’s Disease
- Synthesis and Biological Evaluation of New Benzochromenopyrimidines for the Therapy of Colon and Lung Cancer
- Efficient Two-Step Synthesis of Novel Pyrimido[4,5-d] Pyrimidines with Potent Neuroprotective, Antioxidant, and Aβ Anti-Aggregation Properties
- Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
- Design, Synthesis, in Silico and Biological Evaluation of Novel 4‐Aminopyrimidine‐5‐carbonitriles
- Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
- Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties
- Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2)
- Synthesis and Biological Assessment of PyrimidoTacrines as Promising Agents for Alzheimer's Disease Therapy
- Regioselective Synthesis of Novel [1,2,4]Triazolo[1,5‐ a ]pyridine Derivatives
- Synthesis and Fluorescence of (E)‐3‐Aryl‐2‐(5‐aryl‐4H‐1,2,4‐triazol‐3‐yl) Acrylonitriles
- Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments
- Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer’s Disease Therapy
- New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H 3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
- Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer’s disease therapy
- Synthesis of (±)‐ cis ‐1‐Aryl‐3‐oxo‐2,3‐dihydro‐1 H ‐benzo[ f ]chromene‐2‐carbonitriles and (±)‐ trans ‐4‐Aryl‐2‐oxo‐3,4‐dihydro‐2 H ‐benzo[ h ]chromene‐3‐carbonitriles
- New method for the synthesis of 4-aryl-3,4-dihydro-2H-benzo[g]chromene-2,5,10-triones
- Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
- Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy
- New (Benz)Imidazolopyridino Tacrines as Nonhepatotoxic, Cholinesterase Inhibitors for Alzheimer Disease
- Facile one-pot synthesis of new [1,2,4]triazolo[1,5-a]pyridine derivatives by ultrasonic irradiation
- Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinetriones as Promising Agents for Alzheimer'S Disease Therapy
- Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease
- Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy
- Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease
- Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy
- Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1−42 Aggregation Inhibitors for Alzheimer's Disease Therapy
- Synthesis and biological evaluation of heterocyclic privileged medicinal structures containing (benz)imidazole unit
- Isoxazolotacrines as Non-Toxic and Selective Butyrylcholinesterase Inhibitors for Alzheimer'S Disease
- Nontoxic and Neuroprotective β-Naphthotacrines for Alzheimer’s Disease
- Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease
- Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines
- ChemInform Abstract: Convenient Synthesis of 11‐Aryl‐1,12‐dihydro‐11H‐naphthopyrano[2,3‐d]pyrimidin‐12‐ones.
- Convenient Synthesis of 11-Aryl-1,12-dihydro-11H-naphthopyrano[2,3-d]pyrimidin-12-ones
Revues de publication
- ChemistrySelect × 7
- Molecules × 6
- Synthetic Communications × 3
- Future Medicinal Chemistry × 3
- European Journal of Medicinal Chemistry × 3
- Bioorganic Chemistry × 2
Publications par année
- 20251
- 20242
- 20232
- 20222
- 20214
- 20202
- 20194
- 20182
- 20173
- 20166
Collaborations
Établissements partenaires : Universidad de Alcalá · Instituto de Química Médica · Universidad Complutense de Madrid · Universidad Autónoma de Madrid · Hospital Universitario de La Princesa
Pays des co-auteurs : Tunisie
Co-auteurs
- Isabel Iriepa
- Mourad Chioua
- Ignacio Moraleda
- Daniel Diez‐Iriepa
- Abdelouahid Samadi
- Alejandro Romero
- María Jesús Oset‐Gasque
- Cristóbal de los Rı́os
- Óscar M. Bautista‐Aguilera
- Mario Esquivias-Pérez
- Concepción Pérez
- María Pilar González
Données bibliographiques issues d’OpenAlex (base ouverte).
Pourquoi choisir DzCademia ?
Pour donner à vos travaux plus de chances d’être découverts et recommandés par les IA. Profils, articles et communications : donnez à votre recherche une présence publique structurée. Les métadonnées intégrées aident les moteurs de recherche et les assistants IA à identifier vos travaux et à comprendre leurs références.
Commenter avec Google
Connecte-toi avec Google pour commenter directement sur cette page.